Holen Sie sich die Stockscreener-App
27.93
6.02%
-1.79
Vorhandelsmarkt:
27.17
-0.76
-2.72%
Schlusskurs vom Vortag:
$29.72
Offen:
$29.64
24-Stunden-Volumen:
1.50M
Relative Volume:
1.88
Marktkapitalisierung:
$796.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.47M
KGV:
-4.9899
EPS:
-5.5973
Netto-Cashflow:
$-73.92M
1W Leistung:
-10.74%
1M Leistung:
-42.70%
6M Leistung:
-5.39%
1J Leistung:
+0.00%
1-Tages-Spanne:
$27.10
$29.64
1-Wochen-Bereich:
$27.10
$32.00
52-Wochen-Spanne:
$16.54
$50.40
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Firmenname
Lenz Therapeutics Inc
Sektor
Branche
Telefon
858-925-7000
Adresse
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Vergleichen Sie LENZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
27.93 | 899.65M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-03-18 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Outperform |
| 2024-08-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-04-10 | Eingeleitet | Citigroup | Buy |
| 2024-03-27 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-23 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-02-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | Herabstufung | Cowen | Outperform → Market Perform |
| 2023-01-25 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-06 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-04-14 | Eingeleitet | BTIG Research | Buy |
| 2022-03-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-07-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
Tools to assess LENZ Therapeutics Inc.’s risk profileEarnings Miss & Advanced Swing Trade Entry Alerts - newser.com
Can LENZ Therapeutics Inc. stock maintain operating marginsJuly 2025 Highlights & Verified Short-Term Plans - newser.com
Analyzing drawdowns of LENZ Therapeutics Inc. with statistical tools2025 Short Interest & Accurate Buy Signal Notifications - newser.com
Has LENZ Therapeutics Inc. formed a bullish divergenceJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
How LENZ Therapeutics Inc. stock reacts to oil pricesJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
Why LENZ Therapeutics Inc. stock remains on watchlistsJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Chart overlay techniques for tracking LENZ Therapeutics Inc.Insider Selling & Stock Portfolio Risk Management - newser.com
Is LENZ Therapeutics Inc. trending in predictive chart modelsJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
How LENZ Therapeutics Inc. stock reacts to Fed rate cutsMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Combining price and volume data for LENZ Therapeutics Inc.Day Trade & AI Driven Stock Price Forecasts - newser.com
Ranking LENZ Therapeutics Inc. among high performing stocks via toolsJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Real time scanner hits for LENZ Therapeutics Inc. explainedJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Published on: 2025-11-03 03:22:46 - newser.com
What does recent volatility data suggest for LENZ Therapeutics Inc.Buy Signal & Community Verified Trade Alerts - newser.com
What risks investors should watch in LENZ Therapeutics Inc. stockJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Signal strength of LENZ Therapeutics Inc. stock in tech scannersWeekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com
Will LENZ Therapeutics Inc. continue its uptrendJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Is LENZ Therapeutics Inc. stock ready for a breakoutJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Analyzing net buyer seller activity in LENZ Therapeutics Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Why LENZ Therapeutics Inc. stock is trending among retail tradersGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
Is LENZ Therapeutics Inc. stock a buy in volatile marketsWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com
Will LENZ Therapeutics Inc. stock see PE expansionWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
How LENZ Therapeutics Inc. stock trades before earningsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
How interest rate cuts could boost LENZ Therapeutics Inc. stockShort Setup & Smart Swing Trading Alerts - newser.com
Why LENZ Therapeutics Inc. stock remains undervaluedQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
LENZ Therapeutics, Inc. (LENZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - sharewise.com
Finanzdaten der Lenz Therapeutics Inc-Aktie (LENZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):